![](/img/cover-not-exists.png)
Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients
Sandrine Hayette, Mauricette Michallet, Marie-Laurence Baille, Jean-Pierre Magaud, Franck E. NicoliniVolume:
29
Year:
2005
Language:
english
Pages:
5
DOI:
10.1016/j.leukres.2005.02.006
File:
PDF, 210 KB
english, 2005